Opportunity
DIBBS #SPE2DP-26-T-5005
DLA Solicitation for Hydroxyzine Hydrochloride Tablets, 25 mg, 100-count
Posted
September 11, 2026
Respond By
September 16, 2026
Identifier
SPE2DP-26-T-5005
NAICS
424210
This opportunity involves the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA seeking Hydroxyzine Hydrochloride Tablets for medical supply purposes. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - Office: DLA Troop Support, Philadelphia - OEMs (Original Equipment Manufacturers): - TEVA Pharmaceuticals USA, Inc. (part number NDC00093-5061-01) - KVK-TECH Inc (part number NDC10702-0011-01) - Products Requested: - Hydroxyzine Hydrochloride Tablets, USP, 25 mg, 100 tablets per bottle - NSN: 6505-01-530-3334 - Quantity: 2 bottles - Approved sources: TEVA Pharmaceuticals USA, Inc. and KVK-TECH Inc - Notable Requirements: - Product must comply with DLA packaging and medical marking standards (MIL-STD-2073-1E and Medical Marking Standard No. 1) - Minimum shelf life of 36 months required - Delivery required within 20 days, FOB destination
Description
HYDROXYZINE HYDROCHLOR (QTY: 2, NSN: 6505-01-530-3334, Purchase Request: 7018263140) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-5061-01, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 57JV3, Part No: NDC10702-0011-01, Company: KVK-TECH INC